Indexed in Journament

The Lancet. Oncology

ISSN 1474-5488· EN

Login or register to claim ownership or editorship of this journal.
2
Articles Indexed

About This Journal

Short Name The Lancet. Oncology
Abbreviated Name The Lancet. Oncology
ISSN 1474-5488

Tools & Certificate of Indexing

Publications Per Year

Articles (2)

2021
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Vol. 22 , No. 6 , pp. -
447 views Abstract
2015
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
Vol. 16 , No. 16 , pp. -
338 views Abstract
2021
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Vol. 22 , No. 6 , pp. -
447 views Abstract
2015
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
Vol. 16 , No. 16 , pp. -
338 views Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0